Article By Greg Cima / December 24, 2024
NEW YORK – In 2024, firms in the sepsis testing space made big moves to begin or expand the commercialization of tests that could help reduce the time-to-results, while many also secured funding to compete in an increasingly crowded space.
Outcome Capital Named Top Life Sceneces Investment Banking Firm 2025 by Life Science Review January 2025 Read the full article from Life Science Magazine here: Read More
Read MoreOutcome Capital Life Science Market Pulse January 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?